Results 161 to 170 of about 6,042 (221)

Comprehensive assessment of 5 interleukin inhibitors for the treatment of psoriasis: scientific guidance based on drug selection recommendations for Chinese medical institutions. [PDF]

J Pharm Policy Pract
Zhang JX, Li WW, Qiu ZK, Lai S.
europepmc   +1 more source

Cost-per-Responder Analysis of Bimekizumab (IL-17A/F Inhibitor) Against IL-Inhibitors for Psoriatic Arthritis in Spain, Based on Matching-Adjusted Indirect Comparisons. [PDF]

Rheumatol Ther
Mestre-Ferrandiz J, Navarro-Compán V, Ivanova-Markova Y, González-Domínguez A, Maratia S.   +4 more
europepmc   +1 more source

Guselkumab effectiveness in real-world settings: observations from an Italian multicentre study. [PDF]

Rheumatol Adv Pract
Becciolini A, Marchesoni A, Parisi S, Lo Gullo A, Addimanda O, Celletti E, Idolazzi L, Andracco R, Paroli M, Del Medico P, Farina A, Scolieri P, Ianniello A, Lumetti F, Giampietro C, Mazzanti C, Bezzi A, Visalli E, Bravi E, Volpe A, Vitetta R, Priora M, Ravagnani V, Raffeiner B, Molica Colella AB, Larosa M, Girelli F, Franchina V, Ferrero G, Ometto F, Nucera V, Serale F, Caccavale R, Magnani M, Mansueto N, Smerilli G, Ditto MC, Bixio R, Focherini MC, Mascella F, Di Penta M, Sabatini E, Fiorenza A, Murgia D, Rovera G, Angrisani C, De Simone M, Adorni G, Di Donato E, Santilli D, Foti R, Dal Bosco Y, De Lucia F, Amato G, Molica Colella F, Platè I, Bruzzese V, Bianchi G, Bernardi S, Marchetta A, Foti R, Santoboni G, Camellino D, Cipollone F, Fusaro E, Arrigoni E, Lucchini G, Sandri G, Giuggioli D, Reta M, Ariani A.   +70 more
europepmc   +1 more source

Long-Term Outcomes of Guselkumab and Risankizumab for the Management of Moderate-to-Severe Psoriasis in the Elderly: Results from a Real-World Retrospective Study. [PDF]

J Clin Med
Koumprentziotis IA, Stefanaki I, Routsi E, Vavouli C, Panagakis P, Papoutsaki M, Politou M, Vaiopoulos A, Panou E, Chasapi V, Stratigos A, Nicolaidou E.   +11 more
europepmc   +1 more source

Molecular Improvement of IL-23 Inhibition Revealed by Single-Cell RNA Sequencing in Concurrent Psoriasis and Systemic Lupus Erythematosus. [PDF]

Exp Dermatol
Choi SJ, Lee J, Choi HS, Choi SY, Nam HJ, Huh YJ, Kim HJ, Kim JE.   +7 more
europepmc   +1 more source

Guselkumab for Moderate to Severe Scalp Psoriasis Across All Skin Tones: Cohort B of the VISIBLE Randomized Clinical Trial.

JAMA Dermatol
McMichael A, Shahriari M, Stein Gold L, Alkousakis T, Choi O, Bhutani T, Rodriguez AO, Tyring SK, Chan D, Rowland K, Albrecht L, Lynde C, Yadav G, Yeung J, Park-Wyllie L, Ma T, Jeyarajah J, Gao LL, Smith S, Moore AY, Vashi N, Kindred C, Grimes P, Desai SR, Taylor SC, Alexis A, VISIBLE Trial Investigators.   +26 more
europepmc   +1 more source

Guselkumab for Moderate to Severe Psoriasis Across All Skin Tones: Cohort A of the VISIBLE Randomized Clinical Trial.

JAMA Dermatol
Alexis A, McMichael A, Soung J, Choi O, Alkousakis T, Alonso-Llamazares J, Shahriari M, Rodriguez AO, Bhutani T, Chan D, Rowland K, Sauder M, Hong HC, Yadav G, Yeung J, Jeyarajah J, Ma T, Gao LL, Park-Wyllie L, Green L, Lee M, Vashi N, Kindred C, Grimes P, Taylor SC, Desai SR, VISIBLE Trial Investigators.   +26 more
europepmc   +1 more source